PMID- 25023521 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20141218 LR - 20220321 IS - 1869-6953 (Print) IS - 1869-6961 (Electronic) IS - 1869-6961 (Linking) VI - 5 IP - 2 DP - 2014 Dec TI - Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes. PG - 447-58 LID - 10.1007/s13300-014-0075-x [doi] AB - INTRODUCTION: Severe hypoglycemic events (SHEs) are associated with significant morbidity, mortality and costs. However, the more common non-severe hypoglycemic events (NSHEs) are less well explored. We investigated the association between reported frequency of NSHEs and SHEs among patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) in the PREDICTIVE study. METHODS: PREDICTIVE was a global, prospective, observational study. Patients with T1DM (n = 7,420) or T2DM (n = 12,981), starting treatment with insulin detemir, reported the number of NSHEs and SHEs experienced during the 4 weeks prior to baseline and follow-up visits (mean 14.4 weeks). Logistic regression was used to determine the odds ratio (OR) of experiencing >/=1 SHE, in patients having 1-4 or >/=5 NSHEs, versus those having 0 NSHEs, while controlling for baseline covariates. RESULTS: Hypoglycemia rates were lower at follow-up than baseline. At baseline 59.2% (T1DM) and 18.8% (T2DM) reported any hypoglycemia and at follow-up 39.5% (T1DM) and 8.6% (T2DM). There was a significant (P < 0.0001) increase in the odds of >/=1 SHEs with increasing frequency of NSHEs in T1DM and T2DM, for both crude and adjusted estimates. At baseline, in T1DM, ORs for >/=1 SHE were 1.92 and 2.13 for 1-4 and >/=5 NSHEs, respectively; the corresponding ORs in T2DM were 10.83 and 15.36, respectively. At follow-up, the ORs for >/=1 SHE were 2.01 and 3.20 (T1DM) and 18.99 and 24.29 (T2DM) for 1-4 and >/=5 NSHEs, respectively. CONCLUSION: A statistically significant association between NSHE and SHE frequency was found in T1DM and T2DM. These data provide a clear rationale for the reduction of hypoglycemic events, regardless of severity, while striving for optimal glycemic control. FAU - Sreenan, Seamus AU - Sreenan S AD - Department of Endocrinology, Connolly Hospital, Blanchardstown, Dublin 15, Ireland. FAU - Andersen, Marc AU - Andersen M FAU - Thorsted, Brian Larsen AU - Thorsted BL FAU - Wolden, Michael L AU - Wolden ML FAU - Evans, Marc AU - Evans M LA - eng PT - Journal Article DEP - 20140715 PL - United States TA - Diabetes Ther JT - Diabetes therapy : research, treatment and education of diabetes and related disorders JID - 101539025 PMC - PMC4269646 EDAT- 2014/07/16 06:00 MHDA- 2014/07/16 06:01 PMCR- 2014/07/15 CRDT- 2014/07/16 06:00 PHST- 2014/05/08 00:00 [received] PHST- 2014/07/16 06:00 [entrez] PHST- 2014/07/16 06:00 [pubmed] PHST- 2014/07/16 06:01 [medline] PHST- 2014/07/15 00:00 [pmc-release] AID - 75 [pii] AID - 10.1007/s13300-014-0075-x [doi] PST - ppublish SO - Diabetes Ther. 2014 Dec;5(2):447-58. doi: 10.1007/s13300-014-0075-x. Epub 2014 Jul 15.